The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner
Open accessAbstract
Recently the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product has been identified as a negative regulator of protein synthesis upstream of the mTOR and ribosomal S6 kinases. Because of the homology of TSC2 with GTPase-activating proteins for Rap1, we examined whether a Ras/Rap-related GTPase might be involved in this process. TSC2 was found to bind to Rheb-GTP in vitro and to reduce Rheb GTP levels in vivo. Over-expression of Rheb but not Rap1 promoted the activation of S6 kinase in a rapamycin-dependent manner, suggesting that Rheb acts upstream of mTOR. The ability of Rheb to induce S6 phosphorylation was also inhibited by a farnesyl transferase inhibitor, suggesting that Rheb may be responsible for the Ras-independent anti-neoplastic properties of this drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The TSC complex (TSCC) acts as a GTPase activating protein (GAP) for Rheb, employing a GAP domain within the TSC2 subunit”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Castro et al., 2003
In the citing paper
“This identification of this regulatory mechanism, shown using the human proteins, unequivocally identified TSC1-TSC2 as inhibitors of the mTORC1 signaling pathway (Inoki et al., 2002; Tee et al., 2002), specifically by virtue of TSC2 GAP activity toward the small GTPase Rheb (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003; Saucedo et al., 2003;”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Castro et al., 2003
In the citing paper
“Despite a lack of clear experimental evidence pointing to a defined localization pattern, Rheb is known to function on endomembranes in the mTORC1 pathway as a potent activator of the kinase (Long et al., 2005; Sato et al., 2009) and is the physiologic target of TSC2 (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003; Saucedo et al., 2003; Stocker et al., 2003; Tee et al., 2003; Zhang e”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Castro et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M. D., Yeung, R. S. W., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
RetractedTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
Garami, A., Zwartkruis, F. J. T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L., & Thomas, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00220-x · Cited by 1,043
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A., & Pan, D. (2003) · Nature Cell Biology · doi:10.1038/ncb999 · Cited by 924
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–381 of 381
Upregulation of acid ceramidase contributes to tumor progression in tuberous sclerosis complex
Astrinidis, A., Li, C., Zhang, E. Y., Zhao, X., Zhao, S., Guo, M., Olatoke, T., Mattam, U., Huang, R., Zhang, A. G., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166850 · Cited by 5
Downstream the mTOR: S6 Kinases between Divergence and Redundancy
Ismail, H. M. (2013) · Cited by 5
Sun, S., Li, L., Wu, X., Tang, R., Lei, C., Wang, H., Huang, Y., Nie, Z., & Yao, S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03973 · Cited by 5
Brown, A. B., Mahmood, U., Cortés, M. L., Tang, Y., Dai, G., Stemmer-Rachamimov, A. O., Prabhakar, S., Leishear, K., Onda, H., Kwiatkowski, D. J., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1367 · Cited by 5
Farnesyl Transferase Inhibitors
Bishop, W. R., Doll, R. J., & Kirschmeier, P. T. (2011) · The Enzymes · doi:10.1016/b978-0-12-381339-8.00015-9 · Cited by 5
Ma, S., Zhao, N., Dong, X., Wang, Y., Song, L., Zheng, R., Zhi, X., Ma, C., Cheng, S., Li, J., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03792-0 · Cited by 4
The rapamycin sTORy: 50-year journey from Easter Island to the frontiers of biology and medicine
Xiao, X., & Dokudovskaya, S. (2026) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2026.02.004 · Cited by 4
Branch, M. R., Hsu, C. L., Ohnishi, K., Shen, W.-C., Lee, E., Meisenhelder, J., Winborn, B. J., Sopher, B. L., Taylor, J. P., Hunter, T. R., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201525 · Cited by 4
Brugarolas, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_4 · Cited by 4
Biochemical and biological characterization of tumor-associated mutations of p110alpha.
Denley, A., Gymnopoulos, M., Hart, J., Jiang, H.-T., Zhao, L., & Vogt, P. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(07)38020-8 · Cited by 3
Tuberous Sclerosis Complex: Future Research Directions
Maria, B. L. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190090101 · Cited by 4
mRNA Translation in Diabetic Nephropathy
Kasinath, B. S., Lee, M. J., Féliers, D., & Sonenberg, N. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-153-6_6 · Cited by 4
Tuberous Sclerosis Complex: mutations, functions and phenotypes
Sancak, Ő. (2005) · RePub (Erasmus University Rotterdam) · Cited by 4
Rossetti, C., Alves, B., Peçanha, F. L., Franco, A., Nosé, V., Carneiro, E. M., Lew, J. L., Bernal-Mizrachi, E., & Werneck-de-Castro, J. P. (2023) · bioRxiv · doi:10.1089/thy.2024.0053 · Cited by 3
Zheng, X., Hao, X. Y., Chen, Y., Zhang, X., Yang, J., Wang, Z. G., & Liu, D. J. (2012) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2011.11398 · Cited by 3
Yu, Y., Chang, Y., Li, S., Hu, H., Huang, Q., & Ding, J. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904018232 · Cited by 3
Chotechuang, N. (2010) · HAL · Cited by 3
Cui, Z., Esposito, A., Napolitano, G., Ballabio, A., & Hurley, J. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.15.623810 · Cited by 3
The impact of exercise on cardiovascular system: Molecular signaling pathway and cardiac adaptations
Toktarbay, B., Khamitova, Z. K., Zholshybek, N., Jumadilova, D., Rakhmanov, Y., Bekbossynova, M., Gaipov, A., & Salustri, A. (2023) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/13825 · Cited by 2
Barone, S., Zahedi, K. A., Brooks, M., & Soleimani, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094772 · Cited by 2
An Insight of Scientific Developments in TSC for Better Therapeutic Strategy
Natarajan, N., & Thiruvenkatam, V. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200825170355 · Cited by 2
de Gunzburg, J. (2006) · Springer eBooks · doi:10.1007/1-4020-4708-8_13 · Cited by 2
Structure and Function of the mTOR Activator Rheb
Marshall, C. B., Mazhab‐Jafari, M. T., Stambolic, V., & Ikura, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_13 · Cited by 2
Armijo, M. E., Escalona, E., Peña, D., Farías, A., Morı́n, V., Baumann, M., Klebl, B., Pincheira, R., & Castro, A. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.912688 · Cited by 2
Self-citationZahedi, K. A., Barone, S., Brooks, M., Stewart, T. M., Casero, R. A., & Soleimani, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810601 · Cited by 2
The Role of Target of Rapamycin Signaling in Tuberous Sclerosis Complex
Manning, B. D. (2010) · Wiley eBooks · doi:10.1002/9783527630073.ch6 · Cited by 2
Modeling Tuberous Sclerosis Complex: Brain Development and Hyperexcitability
Ess, K. C. (2009) · Neuromethods · doi:10.1007/978-1-60327-263-6_5 · Cited by 2
AMPK Signaling Regulates Epithelioid Hemangioendothelioma Cell Growth
Kanai, R., McMullan, S., Baniya, P., Dai, R. S., Norton, E., Lasher, K., Purello, C. T., Seavey, C. N., Rubin, B. P., & Lamar, J. M. (2025) · Cancers · doi:10.3390/cancers17172889 · Cited by 2
Ikeda, T., Hong, S., Yoshida, S., Srivastava, S. P., Kunamneni, A., Yao, Y., Khuperkar, O., Basrur, V., Kuang, H., Kachman, M. T., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116382 · Cited by 1
mTORC1: A Signaling Integration Node Involved in Cell Growth
Kubica, N., & Blenis, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_1 · Cited by 1
Mowrey, K., Northrup, H., Hashmi, S. S., & Rodriguez‐Buritica, D. (2022) · Frontiers in Reproductive Health · doi:10.3389/frph.2022.798983 · Cited by 1
Yuan, X., Wang, Q., Dai, M., Wang, H., Xiong, X., Pan, L., & Wang, C. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102342 · Cited by 1
The PI3K Pathway in Colorectal Cancers
Yun, J.-Y., Poulogiannis, G., Brower, E. T., Klempner, S., & Cantley, L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_6 · Cited by 1
Ras Family G-Proteins in Saccharomyces Cerevisiae and Schizosaccharomyces Pombe
Tabancay, A. P., Comiso, M. J., & Tamanoi, F. (2006) · Springer eBooks · doi:10.1007/1-4020-4708-8_10 · Cited by 1
Animal Models of TSC: Insights from Drosophila
Pan, D. (2010) · doi:10.1002/9783527630073.ch8 · Cited by 1
Raghavan, P. R. (2025) · Preprints.org · doi:10.20944/preprints202504.1573.v1
Molecular Pathology and Diagnostics of Pancreatic Endocrine Neoplasms
Nasir, A., Strosberg, J., Kvols, L. K., Muhammad, J., Nasir, N. A., Mills, O. L., & Coppola, D. (2013) · Springer eBooks · doi:10.1007/978-94-007-7192-5_14
CHARACTERIZATION AND TREATMENT OF A NOVEL MOUSE MODEL OF TSC-ASSOCIATED AUTISM
Reith, R. M. (2012) · Digital Commons-TMC (Texas Medical Center)
Prevalence of Premature Ovarian Failure in Women with Tuberous Sclerosis
Gabitzsch, E. K. (2011) · Digital Commons-TMC (Texas Medical Center)
The Role of AMPK in Viral Infection
Moser, T. S. (2011) · ScholarlyCommons (University of Pennsylvania)
Targeting the mTOR Pathway for Tumor Therapeutics
Chen, W. (2009) · Wiley eBooks · doi:10.1002/9780470538951.ch22
Zurashvili, T. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Defining RCE1 and ICMT as Therapeutic Targets in K-RAS-induced Cancer
Wahlstrom, A. M. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Sarkaria, J. N. (2006) · Springer eBooks · doi:10.1007/3-540-35662-2_9
The link between the centrosome, TSC disease and epithelial differentiation
Baldó, L. G. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The tumor suppressing roles of tissue structure in cervical cancer development
Nguyen, H. (2013) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1868
Recent Advances in the Pathogenesis of Pancreatic Endocrine Neoplasms
Mills, O. L., Nasir, N. A., Strosberg, J., Kvols, L. K., Coppola, D., & Nasir, A. (2010) · Springer eBooks · doi:10.1007/978-90-481-3725-1_17
mTOR regulates Aurora A via enhancing protein stability
Li, F. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1876
Function of mTOR complex 1 and 2 in Skeletal Muscle
Fakultät, P.-N. (2009)
Williamson, D. L., Bolster, D. R., Kimball, S. R., & Jefferson, L. S. (2016)
Zhou, X. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Glial Tumors in Neurofibromatosis and Tuberous Sclerosis Complex
Apicelli, A. J., & Gutmann, D. H. (2012) · doi:10.1093/med/9780199794591.003.0060
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Hahn-Windgassen, A. (2005) · doi:10.14279/depositonce-820
The Small Gtpase Rab35 Is A Novel Oncogenic Regulator Of Pi3K/Akt Signaling
Wheeler, D. B. (2015) · eCommons (Cornell University)
Regulation of mRNA translation in renal physiology and
Kasinath, B. S., Féliers, D., Sataranatarajan, K., Choudhury, G. G., Lee, M. J., & Mariappan, M. M. (2009)
Homeostatic role of acid sphingomyelinase in mtor signaling and autophagy
Justice, M. J. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1797
Role of mechanistic Target of Rapamycin (mTOR) signaling in the crustacean molting gland
Abuhagr, A. M., Mykles, D. L., Garrity, D. M., Reddy, A. N., & Curthoys, N. P. (2007) · Digital Collections of Colorado (Colorado State University) · doi:10.25675/3.020423
Key factors in mTOR regulation
Jiang, X. B. (2010)
Autophagy Regulation by Lipid Factors with Implications for Parkinson's Disease
Soto-Avellaneda, A. (2021) · ScholarWorks (Boise State University) · doi:10.18122/td.1847.boisestate
Mecanismes de toxicitat de la dopamina en cèl·lules de neuroblastoma humà SH-SY5Y
Xavier, P. G. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Gleeson, P. A. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738028770.793585376
Unravelling novel functions of the MTOR network across subcellular compartments
Sandoval, M. C. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.208570309
Quilliam, L. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00115-8
Self-citationRole of Akt Signaling and its Downstream Pathways in Wood Frog Freeze Tolerance
Zhang, J. (2013) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2013-09898
Ryu, J. H. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.723347495.793546407
mTORC1: Upstream and Downstream
Yao, Y., & Inoki, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00182-6
Astrinidis, A., Li, C., Zhang, E. Y., Zhao, X., Zhao, S., Guo, M., Huang, R., Zhang, A. G., Kopras, E. J., Gupta, N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.25.509382
Finlay, G. A., Malhowski, A. J., Liu, Y., Fanburg, B. L., Kwiatkowski, D. J., & Toksoz, D. (2023) · doi:10.1158/0008-5472.c.6496451.v1
Finlay, G. A., Malhowski, A. J., Liu, Y., Fanburg, B. L., Kwiatkowski, D. J., & Toksoz, D. (2023) · doi:10.1158/0008-5472.c.6496451
Balasis, M. E., Forinash, K. D., Chen, Y. A., Fulp, W. J., Coppola, D., Hamilton, A. D., Cheng, J. Q., & Sebti, S. M. (2023) · doi:10.1158/1078-0432.c.6519345.v1
Balasis, M. E., Forinash, K. D., Chen, Y. A., Fulp, W. J., Coppola, D., Hamilton, A. D., Cheng, J. Q., & Sebti, S. M. (2023) · doi:10.1158/1078-0432.c.6519345
Javaid, S., Schaefer, A., Goodwin, C. M., Nguyen, V. V., Massey, F. L., Pierobon, M., Gambrell-Sanders, D., Waters, A. M., Lambert, K. N., Diehl, J. N., et al. (2023) · doi:10.1158/1535-7163.22522299
Interplay between Phospholipid signaling and autophagy
Maan, M., & Dutta, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00021-8
Esclerosis Tuberosa: patogénesis molecular y modelos animales
Piedimonte, L. R. (2006) · NeuroTarget · doi:10.47924/neurotarget2006440
Unraveling the Binding Mode of TSC2–Rheb through Protein Docking and Simulations
Pape, B. F., Parate, S., Eriksson, L. A., & Jha, V. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00562
Réseau de contrôle de la traduction par l'Hormone Folliculo-Stimulante
Huamán, K. B. L. (2013) · theses.fr (ABES) · doi:10.70675/d4a25518z7516z44aez84b3zf8a0eb211064
Tuberous sclerosis complex : molecular target of mTORC1 and the role of S6Ks
Bonucci, M. (2019) · theses.fr (ABES) · doi:10.70675/fd5e0059z9c7bz468ezb8bdz4c2214da80c2
EIF4EBP1 in Breast Cancer: Translational Control, Regulatory Networks, and Therapeutic Frontiers
Liu, W., Hou, L., Tang, D., Mou, H., Wang, W., Liu, S., & Li, X. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl45484
Li, H.-H., Yan, S.-L., Chan, Y.-H., Hung, H., Wang, R., Yu, J., & Lai, M. (2026) · Biochemical Engineering Journal · doi:10.1016/j.bej.2026.110419
Mechanisms of Rapamycin Toxicity in Pancreatic Beta Cells
Barlow, A. D. (2011) · Figshare
Metadata
- Authors
- Castro, A. F., Rebhun, J. F., Clark, G. J., & Quilliam, L. A.
- Affiliations
- Indiana University School of Medicine (US)
- National Institutes of Health (US)
- Corresponding author
- Castro, Ariel F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 278
- Issue
- 35
- Pages
- 32493-32496
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1977747566
- Cited by
- 381
- References
- 46
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 15 · 2022: 10 · 2021: 14 · 2020: 15 · 2019: 4 · 2018: 9 · 2017: 3 · 2016: 9 · 2015: 13 · 2014: 17 · 2013: 17 · 2012: 20
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Rheb, tuberous sclerosis complex 2, TSC2, mTOR, rapamycin, farnesylation, farnesyltransferase inhibitors, GTPase-activating protein, protein synthesis regulation, tumor suppressor
- MeSH terms
- Ras Homolog Enriched in Brain Protein, Tuberous Sclerosis Complex 2 Protein, Antineoplastic Agents, Cell Line, Enzyme Activation, Humans, Neuropeptides, Phosphorylation, Plasmids, Protein Binding, Protein Kinases, Repressor Proteins, Immunoblotting, Gene Expression Regulation, Enzymologic, Protein Prenylation, Ribosomal Protein S6 Kinases, Sirolimus, Monomeric GTP-Binding Proteins, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review